Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptevo Therapeutics Inc (NQ: APVO )

0.7400 -0.0300 (-3.90%)
Streaming Delayed Price Updated: 11:05 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Via ACCESSWIRE
Nasdaq Jumps 250 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83.... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Aptevo Therapeutics Stock Is Cratering
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its... 
Via Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
Via Benzinga
Aptevo Therapeutics: Q4 Earnings Insights
Via Benzinga
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Hub Cyber Security (HUBC) Stock Down 7% Today?
Hub Cyber Security stock is falling on Thursday after the company noted an investor sold a large stake of its HUBC shares. 
Via InvestorPlace
Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO. 
Via InvestorPlace
Aptevo Therapeutics: Q3 Earnings Insights
Via Benzinga
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... 
Via Benzinga
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
Via ACCESSWIRE
Aptevo Therapeutics Provides Pipeline Update
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Interim results from the Phase 1 trial of ALG.APV-527 by Alligator Bioscience and Aptevo Therapeutics. Positive signs of clinical activity in breast cancer patients, with well-tolerated treatment and... 
Via Benzinga
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Via ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.